Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Virobay
Virobay
Virobay tees up a $50M IPO to get a trio of candidates into Phase II
Fierce Biotech
Thu, 09/11/14 - 10:46 am
Virobay
IPOs
autoimmune disease
painkillers
Virobay banks $8M to accelerate its treatments for pain, autoimmunity
Fierce Biotech
Thu, 07/17/14 - 10:05 am
Virobay
autoimmune disease
neuropathic pain
VBY-036
VBY-376
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
